The hyperthermia cancer treatment market involves the usage of heat therapy to destroy or reduce the size of tumors. Heat therapy achieves this by damaging and killing cancer cells or making them more sensitive to the effects of radiation and certain anti-cancer drugs. This market utilizes heat treatments like radiofrequency hyperthermia and microwave hyperthermia for tumor ablation.
One of the key trends in the hyperthermia cancer treatment market is the growing adoption of ultra-high radiofrequency hyperthermia. Ultra-high frequencies ranging from 13.56 MHz to 100 MHz are being utilized to treat cancerous tumors localized in the body. The higher frequencies allow for better penetration depth within tissues to destroy tumors effectively. Research and development is ongoing to enhance the utilization of ultra-high frequencies to treat cancers that were previously difficult to treat with hyperthermia. Ongoing clinical research studies are evaluating the safety and efficacy of ultra-high RF hyperthermia to tackle cancers like those in the pancreas and lung. Along with localized therapy, efforts are also examining its role in improving the efficacy of chemotherapy and radiotherapy.
The global hyperthermia cancer treatment market is segmented into two categories based on technology: hyperthermia devices and hyperthermia disposables. The hyperthermia devices segment dominates the market and is expected to continue its dominance over the forecast period. This is because hyperthermia devices such as microwave hyperthermia devices are used repeatedly to treat cancer, making them a worthwhile long-term investment for hospitals and cancer treatment centers.
The Global Hyperthermia Cancer Treatment Market Size is expected to witness high growth, exhibiting a CAGR of 6.1% over the forecast period, due to increasing cases of cancer worldwide.
North America dominates the global hyperthermia cancer treatment market currently due to high awareness regarding cancer treatment options and availability of advanced healthcare facilities in the region. Europe holds the second largest share in the market owing to rising healthcare expenditure and government support for cancer treatment.
Read More
https://healthcarelatesteditionnews.blogspot.com/2023/11/ultra-high-radiofrequency-hyperthermia.html
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian